Gossamer Bio (GOSS) Net Equity Issued and Repurchased (2018 - 2022)

Gossamer Bio's Net Equity Issued and Repurchased history runs 5 years deep, the most recent figure standing at $595000.0 for Q1 2022.

• In Q1 2022, Net Equity Issued and Repurchased fell 21.61% year-over-year to $595000.0; the TTM figure through Mar 2022 stood at -$164000.0 (down 100.14% YoY), while the FY2020 annual figure was $117.1 million, down 59.8% from the prior year.
• Net Equity Issued and Repurchased for Q1 2022 stood at $595000.0, up from -$759000.0 in the prior quarter.
• The five-year high for Net Equity Issued and Repurchased was $291.3 million in Q1 2019, with the low at -$229.6 million in Q4 2018.
• The 5-year median for Net Equity Issued and Repurchased is $677000.0 (2021), against an average of $34.1 million.
• The sharpest annual moves came in 2020 and 2021: Net Equity Issued and Repurchased soared 306578.95% in 2020, then sank 100.65% in 2021.
• Gossamer Bio's Net Equity Issued and Repurchased stood at -$229.6 million in 2018, then surged by 100.02% to $38000.0 in 2019, then plunged by 57.89% to $16000.0 in 2020, then plunged by 4843.75% to -$759000.0 in 2021, then surged by 178.39% to $595000.0 in 2022.
• Business Quant data shows GOSS's Net Equity Issued and Repurchased at $595000.0 in Q1 2022, -$759000.0 in Q2 2021, and $759000.0 in Q1 2021.